The effects of nefazodone on women with seasonal affective disorder: Clinical and polysomnographic analyses

Journal of Psychiatry and Neuroscience

Volumn 30, Issue 1, 2005, Pages 11-16

  Shen, Jianhua ^a,b,d   Kennedy, Sidney H ^a,b   Levitan, Robert D ^a,c   Kayumov, Leonid ^a   Shapiro, Colin M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEFAZODONE; ANTIDEPRESSANT AGENT; TRIAZOLE DERIVATIVE;

ADULT; ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION DIFFICULTY; CURRENT MAJOR DEPRESSIVE EPIDOSE WITH SEASONAL PATTERNS; DEPRESSION; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INCREASED THIRST; LEG MOVEMENT; MAJOR DEPRESSION; OPEN STUDY; PERIODIC LEG MOVEMENT INDEX; POLYSOMNOGRAPHY; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; SEASONAL AFFECTIVE DISORDER; SEASONAL PATTERNS ASSESSMENT QUESTIONNAIRE; SLEEP; SLEEP EFFICIENCY; SLEEP STAGE; SLEEP STAGE 1; STUDENT T TEST; THIRST; TRANQUILIZING ACTIVITY; XEROSTOMIA; DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRES; SEASONAL AFFECTIVE DISORDER; SLEEP STAGES; TRIAZOLES;

EID: 14144251468     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Rosenthal NE, Sack DA, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 1984;41:72-80.
2. Levitt A, Shapiro CM. Seasonal affective disorder. In: Shapiro CM, Fleming JAE, Flanigan MJ, Hanly PH, Kryger M, et al, editors. Sleep solutions manual. 1st ed. Pointe Claire (QC): Kommunicom Publications; 1995. p. 126-46.
3. Magusson A, Axelsson J. The prevalence of seasonal affective disorder is low among descendants of Icelandic emigrants in Canada. Arch Gen Psychiatry 1993;50:947-51.
4. Wirz-Justice A, Graw P, Krauchi K, Gisin B, Jochum A, Arendt J, et al. Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch Gen Psychiatry 1993;50:929-37.
5. Shen J, Shapiro CM. Sleep. In: Partonen T, Magnusson A, editors. Winter seasonal affective disorder, practice and research. 1st ed. Oxford: Oxford University Press; 2001. p. 187-96.
6. Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry 1998;55:883-9.
7. Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry 1998;55:875-82.
8. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas KH, et al. Morning vs evening light treatment of patients with winter depression. Arch Gen Psychiatry 1998;55:890-6.
9. Oren DA, Shannon HJ, Carpenter CJ, Rosenthal NE. Usage patterns of phototherapy in seasonal affective disorder. Compr Psychiatry 1991;32:147-52.
10. Levitt AJ, Joffe RT, Moul DE, Lam RW, Teicher MH, Lebegue B, et al. Side effects of light therapy in seasonal affective disorder. Am J Psychiatry 1993;150:650-2.
11. Praschak-Rieder N, Neumeister A, Hesselmann B, Willeit M, Barnas C, Kasper S. Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases. J Clin Psychiatry 1997;58:389-92.
12. Kogan AO, Guilford PM. Side effects of short-term 10,000-lux light therapy. Am J Psychiatry 1998;155:293-4.
13. Ruhrmann S, Kasper S, Hawellek B, Martinez B, Hoflich G, Nickelsen T, et al. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychol Med 1998;28:923-33.
14. Lam RW, Gorman CP, Michalon M, Steiner M, Levitt AJ, Corral MR, et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry 1995;152:1765-70.
15. Trivedi MH, Rush AJ, Armitage R, Gullion CM, Grannemann BD, Orsulak PJ, et al. Effects of fluoxetine on the polysomnogram in outpatients with major depression. Neuropsychopharmacology 1999;20:447-59.
16. Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994;10:123-7.
17. Levitan RD, Kaplan AS, Brown GM, Vaccarino FJ, Kennedy SH, Levitt AJ, et al. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder. Arch Gen Psychiatry 1998;55:244-9.
18. Neumeister A, Praschak-Rieder N, Hesselmann B, Vitouch O, Rauh M, Barocka A, et al. Rapid tryptophan depletion in drug-free depressed patients with seasonal affective disorder. Am J Psychiatry 1997;154:1153-5.
19. Lam RW, Bowering TA, Tam EM, Grewal A, Yatham LN, Shiah IS, et al. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission. Psychol Med 2000;30:79-87.
20. Skwerer RG, Jacobson FM, Duncan CC, Kelly KA, Tamarkin L, Gaist PA, et al. Neurobiology of seasonal affective disorder and light therapy. J Biol Rhythms 1988;3:135-54.
21. Lam RW, Gorman CP, Michalon M, Steiner M, Levitt AJ, Corral MR, et al. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry 1995;152:1765-70.
22. Eison AS, Eison MS, Torrente JR, Wright RN, Yocca FD. Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 1990;26:311-5.
23. Ansseau M, Darimont P, Lecoq A, De Nayer, Evrard JL, Kremer P, et al. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients. Psychopharmacology 1994;115:254-60.
24. Cyr M, Brown CS. Nefazodone: its place among antidepressants. Ann Pharmacother 1996;30:1006-12.
25. Dunner DL, Laird LK. Comparative safety and tolerability of nefazodone. J Clin Psychiatry 2002;63(Suppl 1):33-6.
26. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington: The Association; 1994.
27. First MB, Spitzer RL, Gibbon M, Williams JBW. The structural clinical interview for DSM-IV (SCID). New York: State Psychiatric Institute; 1995.
28. Williams JBW, Link MJ, Rothenthal NE, Terman M. Structured interview guide for the Hamilton Depression Rating Scale, seasonal affective disorders version (SIGH-SAD). New York: New York Psychiatric Institute; 1988.
29. Rosenthal NE, Wehr TA. Seasonal affective disorders. Psychiatr Ann 1987;17:670-4.
30. Lam RW, Buchanan A, Remick RA. Seasonal affective disorder - a Canadian sample. Ann Clin Psychiatry 1989;1:241-5.
31. Agnew HW, Webb WB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiology 1966;2:263-6.
32. Levitan RD, Shen J, Jindal R, Driver HS, Kennedy SH, Shapiro CM. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. J Psychiatry Neurosci 2000;25:337-46.
33. Shen J, Shapiro C. Polysomnographic sleep effects of fluoxetine and nefazodone on a seasonal affective disorder patient. Sleep Med 2002;3:527-8.
34. Trivedi MH, Rush AJ, Pan JY, Carmody TJ. Which depressed patients respond to nefazodone and when? J Clin Psychiatry 2001;62:158-63.
35. Baldwin DS, Hawley CJ, Mellors K. A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment. J Psychopharmacol 2000;15:161-5
36. Schatzberg AF, Prather MR. Use of nefazodone in major depression. J Clin Psychiatry 2002;63(Suppl 1):19-24.
37. Taylor FB, Prather MR. The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder. Depress Anxiety 2003;18:83-8.
38. Ninan PT, Ruth AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, et al. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. J Clin Psychiatry 2002;63:434-41.
39. DeVane CL, Grothe DR, Smith SL. Pharmacology of antidepressants: focus on nefazodone. J Clin Psychiatry 2002;63:10-7.
40. Yatham LN, Liddle PF, Shiah IS, Scarrow G, Lam RW, Adam MJ, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 2000;57:850-8.
41. Taylor DP, Carter RB, Eison AS, Mullins UL, Smith HL, Torrente JR, et al. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatry 1995;56(Suppl 6):3-11.
42. Horst WD, Preskorn SH. Mechanisms of action and clinical characteristics of 3 atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 1998;51:237-54.
43. Brunner DP, Kräuchi K, Dijk DJ, Leonhardt G, Haug HJ, Wirz-Justice A. Sleep electroencephalogram in seasonal affective disorder and in control women: effects of midday light treatment and sleep deprivation. Biol Psychiatry 1996;40:485-96.
44. Anderson JL, Rosen LN, Mendelson WB, Jacobson FM, Skerer EG, Joseph-Vanderpool JR, et al. Sleep in fall/winter seasonal affective disorder: effects of light and changing season. J Psychosom Res 1994;38:323-37.
45. Armitage R, Yonkers K, Cole D, Rush AJ. A multicenter, double-blind comparison of the effects of nefazodone and fluoxine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 1997;17:161-8.
46. Rush AJ, Armitage R, Gillin JV, Yonkers KA, Winokur A, Moldofsky H, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 1998;44:3-14.
47. Scharf MB, McDannold M, Zaretsky N, Spinner O, Stover R, Berkowitz DV, et al. Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride. Am J Ther 1999;6:77-82.
48. Hicks JA, Argyropoulos SV, Rich AS, Nash JR, Bell CJ, Edwards C, et al. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry 2002;180:528-35.
49. Sharpley AL, Walsh AE, Cowen PJ. Nefazodone - a novel antidepressant - may increase REM sleep. Biol Psychiatry 1992;31:1070-3.
50. Rush AJ, Laird LK, Wright CW. Effects of antidepressants on sleep: focus on nefazodone. J Clin Psychiatry 2002;63(Suppl 1):27-31.
51. Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 1996;126:50-4.
52. Gillin JC, Smith-Vaniz A, Schnierow B, Rapaport MH, Kelsoe J, Raimo E, et al. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J Clin Psychiatry 2001;62:789-96.
53. Sharpley AL, Idzikowski C. Neurotransmitters and sleep. In: Idzikowski C, Cowen PJ, editors. Serotonin, sleep and mental disorder. Petersfield (UK): Wrightson Biomedical Publishing; 1991.
54. Thase ME, Rush AJ, Manber R, Kornstein SG, Klein DN, Markowitz JC, et al. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. J Clin Psychiatry 2002;63:493-500.
55. Staner L, De La Fuente JM, Kerkhofs M, Linkowski P, Mendlewicz J. Biological and clinical features of recurrent brief depression: a comparison with major depressed and healthy subjects. J Affect Disord 1992;26:241-5.
56. Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renarder M. Effects of trazodone on the sleep of depressed subjects - a polygraphic study. Psychopharmacology 1988;95(Suppl):S37-43.
57. Sorensen M, Jorgensen J, Viby-Mogensen J, Bettum V, Dunbar GC, Steffensen K. A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery. Acta Psychiatr Scand 1985;71:339-46.
58. Ruigt GS, Kemp B, Groenhout CM, Kamphuisen HA. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990;38:551-4.
59. Winokur A, Sateis MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000;48:75-8.